showed a trendP = 0.075
Additionally, MD‐CMML patients with MLR > 1 showed a trend toward a higher prevalence of CBL mutations (17.9% vs. 6.7%; P = 0.075).
Additionally, MD‐CMML patients with MLR > 1 showed a trend toward a higher prevalence of CBL mutations (17.9% vs. 6.7%; P = 0.075).